{"comparisonGroups":["Wild_Type","TMAVA_Treatment"],"dateCreated":"2025-09-26 00:00:00","display_title":"Mouse: Wild type vs TMAVA treatment","group_a_title":"Wild type mice with no treatment or knockout.. Serves as the reference group for evaluating the effects of TMAVA treatment and BBOX knockout.","group_b_title":"Wild type mice treated with TMAVA.. Crucial for evaluating the pathophysiological effects of TMAVA on cardiac hypertrophy.","id":"MTBLS3174_0003_00000002","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":7,"studyId":"MTBLS3174","studyUrl":"http://integmet.org/study/MTBLS3174","title":"Wild_Type_vs_TMAVA_Treatment","topHits":[{"chebi_id":"74963","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-2-[(4<i>Z</i>,7<i>Z</i>,10<i>Z</i>,13<i>Z</i>,16<i>Z</i>,19<i>Z</i>)-docosa-4,7,10,13,16,19-hexaenoyloxy]-3-(palmitoyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"IESVDEZGAHUQJU-ZLBXKVHBSA-N","pvalue":1.0558507185627774e-08,"ratio":14.076632132872884,"synonym_name":"Phosphatidylcholine(16:0/22:6\u03c93)"},{"chebi_id":"76233","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-1-{[(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-3-hydroxypropan-2-yl (9<i>Z</i>,12<i>Z</i>)-octadeca-9,12-dienoate","metabolite_id":"SVRBKLJIDJHADS-USWSLJGRSA-N","pvalue":4.466283926091906e-05,"ratio":0.149090909090909,"synonym_name":"LPE(18:2)"},{"chebi_id":"28733","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-2-hydroxy-3-[(9<i>Z</i>,12<i>Z</i>)-octadeca-9,12-dienoyloxy]propyl 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"SPJFYYJXNPEZDW-FTJOPAKQSA-N","pvalue":2.516211614378414e-05,"ratio":0.2618282039503904,"synonym_name":"1-Linoleoylglycerophosphocholine"},{"chebi_id":"72749","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-1-{[(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-3-hydroxypropan-2-yl (4<i>Z</i>,7<i>Z</i>,10<i>Z</i>,13<i>Z</i>,16<i>Z</i>,19<i>Z</i>)-docosa-4,7,10,13,16,19-hexaenoate","metabolite_id":"TWBVHOYVCUOMJY-PAUXXPOVSA-N","pvalue":2.064414158151323e-05,"ratio":3.107717041800643,"synonym_name":"LPE 0:0/22:6(4<i>Z</i>,7<i>Z</i>,10<i>Z</i>,13<i>Z</i>,16<i>Z</i>,19<i>Z</i>)"},{"chebi_id":"74344","direction":"up","inn_name":"","iupac_name":"(2<i>R</i>)-2-hydroxy-3-[(5<i>Z</i>,8<i>Z</i>,11<i>Z</i>,14<i>Z</i>)-icosa-5,8,11,14-tetraenoyloxy]propyl 2-(trimethylammonio)ethyl phosphate","metabolite_id":"LAXQYRRMGGEGOH-JXRLJXCWSA-N","pvalue":3.764474650486878e-05,"ratio":2.6636597938144333,"synonym_name":"PC(20:4(5<i>Z</i>,8<i>Z</i>,11<i>Z</i>,14<i>Z</i>)/0:0)"},{"chebi_id":"72741","direction":"down","inn_name":"","iupac_name":"(2<i>R</i>)-1-{[(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-3-hydroxypropan-2-yl (5<i>Z</i>,8<i>Z</i>,11<i>Z</i>,14<i>Z</i>)-icosa-5,8,11,14-tetraenoate","metabolite_id":"YWOCITMXHHTBAW-XSQXPFHXSA-N","pvalue":0.0001406732332456,"ratio":0.5,"synonym_name":"Lyso-PE(0:0/20:4(5<i>Z</i>,8<i>Z</i>,11<i>Z</i>,14<i>Z</i>))"},{"chebi_id":"145254","direction":"down","inn_name":"","iupac_name":"","metabolite_id":"CZYOFWNORPEFDG-KOIKXXGWSA-N","pvalue":8.66589564105886e-05,"ratio":0.5768511093290564,"synonym_name":"LysoPE(0:0/18:1(11Z))"}],"totalFeatures":11}